Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 CFR 310.306 Notification of a permanent discontinuance or an interruption in manufacturing of marketed prescription drugs for human use without approved new drug applications.
21 CFR 310.306 Notification of a permanent discontinuance or an interruption in manufacturing of marketed prescription drugs for human use without approved new drug applications., “Notification of a permanent discontinuance or an interruption in manufacturing of marketed prescription drugs for…”, is a CFR section of 21 CFR Part 310, Subpart D—Records and Reports; in force.
https://ontology.bommaritollc.com/id/01a0f094-c475-70cd-a13a-5fc6c8b9272d
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 CFR 310.306 |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Notification of a permanent discontinuance or an interruption in manufacturing of marketed prescription drugs for human use without approved new drug applicationsen |
| schema:url | |
| skos:prefLabel | 21 CFR 310.306 Notification of a permanent discontinuance or an interruption in manufacturing of marketed prescription drugs for human use without approved new drug applications.en |